By passing the RESTORE Patent Rights Act without delay, lawmakers can bring common sense fairness back to our nation’s patent ...
In December, LabCorp, a healthcare diagnostics company in Burlington, North Carolina, received a patent that appears to cover any test that can identify three variants in the gene HOMER1. The patent ...
The Federal Circuit directed the International Trade Commission to revive its investigation into whether retailers and makers ...
Hosted on MSN1mon
bioAffinity secures Australian patent for lung cancer testThe patent, which supports the CyPath® Lung diagnostic test, is set to expand the company's intellectual property portfolio and enhance its market reach. With a current market capitalization of $ ...
The objectives of this study were to identify US patents that protect existing panels of genetic tests, describe how (or if) test providers acquired rights to these patents, and determine if ...
Qiagen alleges that BioMérieux infringes a European patent that protects the company's QuantiFeron interferon-gamma release assay technology for latent TB detection.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback